Today before
the opening bell, International Stem Cell Corp. announced that Mahnaz Ebrahimi
will be taking over as the new chief financial officer, effective September 14,
2015. The prior CFO, Jay Novak, ended his employment in May.
Ms. Ebrahimi is
a certified public accountant, a certified equity professional and a certified
cash manager. She has more than 25 years of experience in financial management
and accounting of growing research-driven companies in the life sciences,
biotechnology, and pharmaceutical sectors. Most recently, she has been
assisting several biotechnology and technology companies on accounting and SEC
related matters in an expert consultancy capacity, including Flux Power
Holdings, Polaris Pharmaceuticals and Ocera Therapeutics.
From 2010 until
an acquisition took place in 2012, Ms. Ebrahimi served as director of Finance
and Planning, as well as Treasury, of eBioscience. She also served as vice
president of Finance and Administration and chief financial officer of Profil
Institute for Clinical Research from 2003 to 2005. From 1989 to 2000, she
served as director of Finance & Treasury and assistant controller of
Agouron Pharmaceuticals, which became a subsidiary of Pfizer in 2000.
For those
unfamiliar with International Stem Cell Corp., it is a California-based
biotechnology company focused on the therapeutic applications of human
parthenogenetic stem cells (hpSCs) and the development and commercialization of
cell-based research and cosmetic products. ISCO’s core technology, parthenogenesis,
results in the creation of pluripotent human stem cells from unfertilized
oocytes (eggs). ISCO also produces and markets specialized cells and growth
media for therapeutic research worldwide through its subsidiary Lifeline Cell
Technology, and stem cell-based skin care products through its subsidiary
Lifeline Skin Care.
For more
information, visit www.internationalstemcell.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
